Item 2.02 Results of Operations and Financial Condition.

On August 12, 2021, 4D Molecular Therapeutics, Inc. ("4DMT") announced its unaudited financial results for the quarter ended June 30, 2021. A copy of 4DMT's press release, titled "4D Molecular Therapeutics Reports Financial Results for the Second Quarter of 2021 and Provides Operational Highlights," is furnished pursuant to Item 2.02 as Exhibit 99.1 hereto.

Item 9.01 Financial Statements and Exhibits.



(d) Exhibits.



Exhibit
Number                                  Description
99.1        Press Release, dated August 12, 2021 titled "4D Molecular Therapeutics
          Reports Financial Results for the Second Quarter of 2021 and Provides
          Operational Highlights"
104       Cover Page Interactive Data File (embedded within the Inline XBRL
          document)


                                       1

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses